Silo Pharma Statistics

Total Valuation

Silo Pharma has a market cap or net worth of $3.48 million. The enterprise value is -$3.26 million.

Market Cap	3.48M
Enterprise Value	-3.26M

Important Dates

The last earnings date was Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Silo Pharma has 3.69 million shares outstanding. The number of shares has decreased by -9.24% in one year.

Shares Outstanding	3.69M
Shares Change (YoY)	-9.24%
Shares Change (QoQ)	-1.09%
Owned by Insiders (%)	5.97%
Owned by Institutions (%)	3.06%
Float	2.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.32
Forward PS	n/a
PB Ratio	0.66
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.87, with zero debt.

Current Ratio	7.87
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-706.31

Financial Efficiency

Return on equity (ROE) is -52.80% and return on invested capital (ROIC) is -74.29%.

Return on Equity (ROE)	-52.80%
Return on Assets (ROA)	-42.40%
Return on Capital (ROIC)	-74.29%
Revenue Per Employee	$24,034
Profits Per Employee	-$1.20M
Employee Count	3
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.90% in the last 52 weeks. The beta is 1.48, so Silo Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-52.90%
50-Day Moving Average	1.59
200-Day Moving Average	1.61
Relative Strength Index (RSI)	33.06
Average Volume (20 Days)	319,549

Short Selling Information

The latest short interest is 34,186, so 0.93% of the outstanding shares have been sold short.

Short Interest	34,186
Short Previous Month	107,218
Short % of Shares Out	0.93%
Short % of Float	1.30%
Short Ratio (days to cover)	0.45

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$3.60 million in losses. Loss per share was -$1.19.

Revenue	72,102
Gross Profit	66,264
Operating Income	-3.93M
Pretax Income	-3.60M
Net Income	-3.60M
EBITDA	-3.59M
EBIT	-3.59M
Loss Per Share	-$1.19

Full Income Statement

Balance Sheet

The company has $6.74 million in cash and no debt, giving a net cash position of $6.74 million or $1.83 per share.

Cash & Cash Equivalents	6.74M
Total Debt	n/a
Net Cash	6.74M
Net Cash Per Share	$1.83
Equity (Book Value)	5.29M
Book Value Per Share	1.44
Working Capital	6.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.37M
Capital Expenditures	n/a
Free Cash Flow	-3.37M
FCF Per Share	-$1.18

Full Cash Flow Statement

Margins

Gross margin is 91.90%, with operating and profit margins of -5,452.86% and -4,987.32%.

Gross Margin	91.90%
Operating Margin	-5,452.86%
Pretax Margin	-4,987.32%
Profit Margin	-4,987.32%
EBITDA Margin	-4,980.26%
EBIT Margin	-4,980.26%
FCF Margin	-4,673.92%

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.24%
Shareholder Yield	9.24%
Earnings Yield	-103.21%
FCF Yield	-96.73%

Analyst Forecast

The average price target for Silo Pharma is $10.00, which is 956.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	956.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Silo Pharma has an Altman Z-Score of -1.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.75
Piotroski F-Score	3